微门户首页  新闻  讨论区  活动  博客  求职招聘  行业报告  圈内成员  供应   
已读[426] 发布: 2013/06/18 17:33:32
中金在线 中长期趋势向上确定性强:我们认为三个核心品种瑞舒伐他汀、康复新液和地衣芽孢杆菌都有望成为3亿元以上的中型品种;而在研品种中也不乏阿托伐他汀、 氯吡格雷 等大品种,长期来看,公司的制剂业务未来  ... 更多 »
已读[736] 发布: 2013/06/18 14:15:27
核心品种持续发力,驱动业绩高增长:主力品种瑞舒伐他汀和康复新液竞争结构良好,市场潜力大,都处在快速成长期,未来三年都有望保持50%以上的高增长,是公司业绩增长的主要动力;此外,新产品地衣芽孢杆菌纳入新版基药目录,由于产品竞争结构良好,...
已读[1067] 发布: 2013/06/17 00:59:18
高血压用药:非洛地平、拉西地平、氨氯地平、比索洛尔、卡维地洛、培哚普利、福新普利、厄贝沙坦、氯沙坦钾、替米沙坦、颉沙坦、阿托伐他汀、氟伐他汀、洛伐他汀。 9...
已读[263] 发布: 2013/06/16 11:58:47
NewsClick It is qquite possible that Ranbaxy lied and cooked up data in its hurry to get into the US market. Specifically, it had an interest in being the first generic to enter the US market for Atorvastatin (an anti-cholesterol drug sold under the brand name ... and more »
已读[257] 发布: 2013/06/16 11:58:41
Counsel & Heal The shoppers asked for the generic versions of five best-selling drugs: Actos (pioglitazone), for diabetes; Lexapro (escitalopram), for depression; Lipitor ( atorvastatin ), for high cholesterol; Plavix (clopidogrel), a blood thinner; and Singulair ...
已读[328] 发布: 2013/06/15 18:34:51
搜狐 高血压用药:非洛地平、拉西地平、氨氯地平、比索洛尔、卡维地洛、培哚普利、福新普利、厄贝沙坦、氯沙坦钾、替米沙坦、颉沙坦、 阿托伐他汀 、氟伐他汀、洛伐他汀。 9家社区医院名单思明区鼓浪屿街道社区卫生  ...
已读[180] 发布: 2013/06/15 18:30:31
NEWS.com.au (blog) Consumers could save over $18 per script on the cholesterol lowering medicine atorvastatin if the scheme allowed them to pay the market price for the drug instead of an inflated price that lines the pockets of chemists. More than 10.5 million ... and more »
已读[1500] 发布: 2013/06/15 14:50:37
实行延时服务,有利于缓解大医院“就诊难”问题。(资料图片) 大医院人太挤,上班...比索洛尔、卡维地洛、培哚普利、福新普利、厄贝沙坦、氯沙坦钾、替米沙坦、颉沙坦...
已读[241] 发布: 2013/06/15 14:20:43
AARP News These rebates reduced the cost of Lipitor to less than the cost of the generic version of Lipitor (known as atorvastatin sodium) and in exchange, insurance plans and PBMs rejected atorvastatin claims for six months, effectively preventing pharmacists ...
已读[267] 发布: 2013/06/15 14:20:02
OncLive Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre  ...
« 上一页  |   查看结果131-140共364   |  下一页 »

新闻标签:

没有标签


最新报告


求职招聘